Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Friday morning. The firm issued a hold rating on the stock.

Retractable Technologies Trading Down 1.6 %

NYSE RVP opened at $0.78 on Friday. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The business has a fifty day simple moving average of $0.72 and a 200 day simple moving average of $0.80. Retractable Technologies has a 12 month low of $0.56 and a 12 month high of $1.34. The firm has a market capitalization of $23.26 million, a P/E ratio of -1.44 and a beta of 1.96.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC acquired a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent quarter. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.